KRAFTON Achieves Record-High Quarterly Sales in Q1 2025
KRAFTON achieved significant growth across all of its business divisions, including PC (323.5B KRW), mobile (532.4B KRW), and console/others (18.3B KRW).
Significant Growth and Core IP Direction
KRAFTON achieved significant growth across all of its business divisions, including PC (323.5B KRW), mobile (532.4B KRW), and console/others (18.3B KRW). On PC platforms, PUBG: BATTLEGROUNDS ' diversified content and strong live-service operations contributed significantly to growth while the successful launch of a new IP, inZOI, also played a pivotal role. On mobile, premium items, strategic IP collaborations, and localized marketing efforts drove increased sales. This was especially true for BATTLEGROUNDS MOBILE INDIA (BGMI), which generated positive player response through notable collaborations, including one with Indian automobile manufacturer Mahindra, which achieved the highest localized sales-to-date for the title.
The all-time high first quarter success can be attributed to the expansion of the PUBG IP franchise, as well as KRAFTON's ongoing strategy of securing a 'Big Franchise IP.' Since its transition to a Free-to-Play (F2P) model, PUBG has demonstrated its sustainability by surpassing 1.4 million concurrent users in March. Moving forward, KRAFTON will continue to enhance the player experience through collaborations with renowned artists and brands, new maps, and different game modes. The company also plans to broaden its player base and global presence by releasing new PUBG-based titles, including the extraction shooter Project Black Budget, the console-focused battle royale Project Valor, and the top-down tactical shooter PUBG: BLINDSPOT. By adopting photorealistic graphics powered by Unreal Engine 5 and introducing user-generated content (UGC), KRAFTON aims to evolve PUBG into a comprehensive 'PUBG 2.0' gaming platform.
KRAFTON's results can also be linked back to inZOI, which launched in Early Access on March 28 and sold over one million copies in its first week, becoming the fastest-selling KRAFTON title ever. Approximately 95% of its sales came from global markets, showcasing KRAFTON's strength in creating a globally successful original IP. By continuing to leverage the title's advanced CPC (Co-Playable Character) AI technology, Smart Zoi, KRAFTON plans to enhance gameplay and develop inZOI into another long-term franchise IP.
Exciting New Titles and Strategic Expansion in India
KRAFTON is strategically tailoring its development and publishing approach to each of its new titles. The PC life simulation game Dinkum officially launched globally on April 23 with localization expanded to 14 languages. The company plans to strengthen the Dinkum IP franchise by expanding it to new platforms and launching a spin-off game called Dinkum Together. Additionally, the highly anticipated Subnautica 2 is scheduled for Early Access later this year and aims to actively integrate player feedback into future development.
In addition to new titles, a core strategic market for KRAFTON continues to be India, where it is focused on solidifying its market position after strong growth with BGMI. In March, the company acquired a controlling stake in Indian studio Nautilus Mobile and secured the IP for Real Cricket, India's leading cricket game with over 250 million downloads and 10 million monthly active users. Building on this momentum, KRAFTON will further strengthen its localized strategy through new content, targeted marketing, additional game publishing, and ongoing business development efforts to discover its next major IP in India.
Quarterly Financial Highlights (Unit: KRW 100M)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
30 minutes ago
- Business Wire
Birks Group Inc. Reports Fiscal 2025 Results
MONTREAL--(BUSINESS WIRE)--Birks Group Inc. (the 'Company' or 'Birks Group') (NYSE American: BGI), today reported its financial results for the fiscal year ended March 29, 2025. All figures presented herein are in Canadian dollars. For the fiscal year ended March 29, 2025 ('fiscal 2025'), the Company reported net sales of $177.8 million, a decrease of $7.5 million or 4.0%, from the comparable fiscal year ended March 30, 2024 ('fiscal 2024'). Comparable store sales for fiscal 2025 decreased by 3.4% compared to the corresponding period in fiscal 2024. The decrease in net sales and comparable store sales is mainly due to lower sales of branded jewelry due to the exit of a jewelry brand from two stores. When excluding the third-party jewelry brand movement, the comparable store sales increased by 6.9%, mainly driven by timepiece sales. The Company reported gross profit of $66.3 million, or 37.3% of net sales, compared to $73.6 million, or 39.7% of net sales in fiscal 2024, due to lower sales volume resulting from the exit of a jewelry brand from two stores. Gross profit as a percentage of sales for fiscal 2025 was 37.3%, a decrease of 240 basis points from the gross profit as a percentage of sales of 39.7% for fiscal 2024 as a result of the sales mix with decreased sales from third-party branded jewelry, as well as a foreign exchange loss. Mr. Jean-Christophe Bédos, President and Chief Executive Officer of Birks Group, commented: 'Although our net sales and comparable store sales for fiscal 2025 are lower than fiscal 2024, when excluding the effect of third-party jewelry brand movement, comparable store sales are positive year-over-year, as a result of a strong retail performance and product offering particularly in our third-party branded timepieces. In fiscal 2025, we opened two new stores under the TimeVallée and Birks brands and continued to benefit from the fiscal 2024 renovations in our Chinook and Laval locations. These initiatives along with our recent announcement of the acquisition of the watch and jewelry business of European Boutique will continue to generate greater sales and contribute to improve our results.' Mr. Bédos further commented: 'I would like to thank our teams for their tireless efforts. The results achieved in fiscal 2025 are a testament to our commitment to our customers and I am grateful for the unwavering efforts of all our employees and the implementation of various initiatives during this past year to enhance our product offering and customer experience.' Financial overview for the fiscal year ended March 29, 2025: Total net sales for fiscal 2025 were $177.8 million compared to $185.3 million in fiscal 2024, a decrease of $7.5 million, or 4.0%. The decrease in net sales in fiscal 2025 was primarily driven by the results of the Company's retail channel. Net retail sales in fiscal 2025 were $7.3 million lower than fiscal 2024, primarily due to the decrease in third-party branded jewelry sales, following the exit of a jewelry brand from two stores, partially offset by an increase in branded timepiece sales throughout the retail network; Comparable store sales decreased by 3.4% in fiscal 2025 compared to fiscal 2024 mainly due to lower third-party branded jewelry sales following the exit of a jewelry brand from two stores, partially offset by an increase in third-party branded timepiece sales and an increase in average sales transaction value. When excluding the third-party jewelry brand movement, the comparable store sales increased by 6.9%, mainly driven by timepiece sales; Total gross profit for fiscal 2025 was $66.3 million, or 37.3% of net sales, compared to $73.6 million, or 39.7% of net sales, in fiscal 2024. This decrease in gross profit was primarily due to the decreased sales volume experienced during fiscal 2025, due to third-party branded jewelry sales following the exit of a jewelry brand from two stores, and a foreign exchange loss due to the strengthening of the U.S. dollar, partially offset by the increased sales of third-party branded timepieces. The decrease of 240 basis points in gross margin percentage resulted primarily from the sales mix with decreased sales from third-party branded jewelry, as well as a foreign exchange loss, partially offset by an increase in branded timepiece sales; SG&A expenses in fiscal 2025 were $59.5 million, or 33.5% of net sales, compared to $65.7 million, or 35.5% of net sales, in fiscal 2024, a decrease of $6.2 million. The main drivers of the decrease in SG&A expenses in fiscal 2025 include lower occupancy costs ($2.7 million) mainly due to store closures and store lease modifications, lower marketing costs ($2.3 million) mainly due to lower brand development initiatives, lower compensation costs ($0.5 million) mainly due to lower sales volume and head count reductions, lower general operating costs ($0.4 million) and lower non-cash based compensation expense ($0.3 million) mainly due to fluctuations in the Company's stock price during the fiscal year. As a percentage of sales, SG&A expenses in fiscal 2025 decreased by 200 basis points as compared to fiscal 2024, reflecting the Company's focus on cost management and containment; The Company's adjusted EBITDA (1) for fiscal 2025 was $9.2 million, a decrease of $0.8 million, compared to adjusted EBITDA (1) of $10.0 million for fiscal 2024; The Company's reported operating loss for fiscal 2025 was $5.5 million, a decrease of $6.7 million, compared to a reported operating income of $1.2 million for fiscal 2024. The operating loss in fiscal 2025 includes an impairment of long-lived assets of $4.6 million related to the write-down of capitalized software costs associated with the delay in completing the implementation of the Company's ERP system; The Company's recognized interest and other financing costs were $9.7 million in fiscal 2025, an increase of $1.7 million, compared to recognized interest and other financing costs of $8.0 million in fiscal 2024. This increase is mainly due to an increase in the average amount outstanding on the amended credit facility, additional borrowings, and a foreign exchange loss of $1.0 million in fiscal 2025 versus a foreign exchange gain of $0.2 million in fiscal 2024 on our U.S. dollar denominated debt; The Company recognized a net loss for fiscal 2025 of $12.8 million, or $0.66 per share, compared to a net loss for fiscal 2024 of $4.6 million, or $0.24 per share. (1) This is a non-GAAP financial measure defined below under 'Non-GAAP Measures' and accompanied by a reconciliation to the most directly comparable GAAP financial measure. Expand About Birks Group Inc. Birks Group is a leading designer of fine jewelry and an operator of luxury jewelry, timepieces and gifts retail stores in Canada. The Company operates 17 stores under the Maison Birks brand in most major metropolitan markets in Canada, one retail location in Montreal under the Birks brand, one retail location in Montreal under the TimeVallée brand, one retail location in Calgary under the Brinkhaus brand, one retail location in Vancouver under the Graff brand, one retail location in Vancouver under the Patek Philippe brand, four retail locations in Laval, Ottawa and Toronto under the Breitling brand, four retail locations in Toronto under the European Boutique brand, one retail location in Toronto under the Omega brand and one retail location in Toronto under the Montblanc brand. Birks was founded in 1879 and has become Canada's premier designer and retailer of fine jewelry, timepieces and gifts. Additional information can be found on Birks' web site, NON-GAAP MEASURES The Company reports financial information in accordance with U.S. Generally Accepted Accounting Principles ('U.S. GAAP'). The Company's performance is monitored and evaluated using various sales and earnings measures that are adjusted to include or exclude amounts from the most directly comparable GAAP measure ('non-GAAP measures'). The Company presents such non-GAAP measures in reporting its financial results to assist in business decision-making and to provide key performance information to senior management. The Company believes that this additional information provided to investors and other external stakeholders will allow them to evaluate the Company's operating results using the same financial measures and metrics used by the Company in evaluating performance. The Company does not, nor does it suggest that investors and other external stakeholders should, consider non-GAAP measures in isolation from, or as a substitute for, financial information prepared in accordance with U.S. GAAP. These non-GAAP measures may not be comparable to similarly titled measures presented by other companies. In addition to our results determined in accordance with U.S. GAAP, we use non-GAAP measures including 'EBITDA' and 'Adjusted EBITDA'. EBITDA 'EBITDA' is defined as net income (loss) before interest expense and other financing costs, income taxes expense (recovery) and depreciation and amortization. Forward Looking Statements This press release contains forward- looking statements which can be identified, for example, by their use of words such as 'plans,' 'expects,' 'believes,' 'will,' 'anticipates,' 'intends,' 'projects,' 'estimates,' 'could,' 'would,' 'may,' 'planned,' 'goal,' and other words of similar meaning. All statements that address expectations, possibilities or projections about the future, including without limitation, statements about anticipated economic conditions, generation of shareholder value, and our strategies for growth, performance drivers, expansion plans, sources or adequacy of capital, expenditures and financial results are forward-looking statements. Because such statements include various risks and uncertainties, actual results might differ materially from those projected in the forward- looking statements and no assurance can be given that the Company will meet the results projected in the forward-looking statements. Accordingly, the reader should not place undue reliance on forward-looking statements. These risks and uncertainties include, but are not limited to the following: (i) a decline in consumer spending or deterioration in consumer financial position; (ii) economic, political and market conditions, including the economies of Canada and the U.S. and the influence of inflation on consumer spending, which could adversely affect the Company's business, operating results or financial condition, including its revenue and profitability, through the impact of changes in the real estate markets, changes in the equity markets and decreases in consumer confidence and the related changes in consumer spending patterns, the impact on store traffic, tourism and sales as well as the recently imposed tariffs (and retaliatory measures), possible changes therefrom and other trade restrictions; (iii) the impact of fluctuations in foreign exchange rates, increases in commodity prices and borrowing costs and their related impact on the Company's costs and expenses; (iv) the Company's ability to maintain and obtain sufficient sources of liquidity to fund its operations, to achieve planned sales, gross margin and net income, to keep costs low, to implement its business strategy, maintain relationships with its primary vendors, to source raw materials, to mitigate fluctuations in the availability and prices of the Company's merchandise, to compete with other jewelers, to succeed in its marketing initiatives (including with respect to Birks branded products), and to have a successful customer service program; (v) the Company's plan to evaluate the productivity of existing stores, close unproductive stores and open new stores in new prime retail locations, renovate existing stores and invest in its website and e-commerce platform; (vi) the Company's ability to execute its strategic vision; and (vii) the Company's ability to invest in and finance capital expenditures; (viii) the Company's ability to maintain its listing on the NYSE American exchange or to list its shares on another national securities exchange; and (ix) the Company's ability to continue as a going concern. Information concerning the above and other risk factors that could cause actual results to differ materially is set forth under the captions 'Risk Factors' and 'Operating and Financial Review and Prospects' and elsewhere in the Company's Annual Report on Form 20-F filed with the Securities and Exchange Commission on July 25, 2025 and subsequent filings with the Securities and Exchange Commission. The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law. BIRKS GROUP INC. CONSOLIDATED BALANCE SHEETS (In thousands) As of March 29, 2025 March 30, 2024 Assets Current Assets Cash and cash equivalents $ 1,509 $ 1,783 Accounts receivable and other receivables 6,608 8,455 Inventories 116,277 99,067 Prepaids and other current assets 2,072 2,913 Total current assets 126,466 112,218 Long-term receivables 1,084 1,571 Equity investment in joint venture 5,169 4,122 Property and equipment 25,380 25,717 Operating lease right-of-use asset 34,964 51,753 Intangible assets and other assets 3,017 7,887 Total non-current assets 69,614 91,050 Total assets $ 196,080 $ 203,268 Liabilities and Stockholders' Equity (Deficiency) Current liabilities Bank indebtedness $ 73,630 $ 63,372 Accounts payable 58,114 43,011 Accrued liabilities 6,053 6,112 Current portion of long-term debt 4,860 4,352 Current portion of operating lease liabilities 6,929 6,430 Total current liabilities 149,586 123,277 Long-term debt 21,374 22,587 Long-term portion of operating lease liabilities 38,629 59,881 Other long-term liabilities 4,502 2,672 Total long-term liabilities 64,505 85,140 Stockholders' equity (deficiency): Class A common stock – no par value, unlimited shares authorized, issued and outstanding 11,876,717 (11,447,999 as of March 30, 2024) 42,854 40,725 Class B common stock – no par value, unlimited shares authorized, issued and outstanding 7,717,970 57,755 57,755 Preferred stock – no par value, unlimited shares authorized, none issued — — Additional paid-in capital 19,719 21,825 Accumulated deficit (138,295 ) (125,476 ) Accumulated other comprehensive income (loss) (44 ) 22 Total stockholders' equity (deficiency) (18,011 ) (5,149 ) Total liabilities and stockholders' equity (deficiency) $ 196,080 $ 203,268 Expand
Time Magazine
31 minutes ago
- Time Magazine
Breaking Down the Ending of Netflix K-Drama 'Trigger'
If Trigger were a U.S. production, the action thriller that follows a police force as they deal with an influx of guns into their city wouldn't have a very novel premise. In the U.S., where gun violence was declared a public health crisis last year, there are more guns than there are people, with an estimated 120.5 guns per every 100 people. But in South Korea, where Trigger is set, there are only 0.2 guns per every 100 people. Korean gun control laws are strict, and the weapons are practically a non-issue when it comes to public safety. While gun violence does occur, as was the case last week when a father shot his adult son using a homemade gun, it is a rarity in Korea, where private gun ownership is uncommon. According to a 2022 article in the Korea Herald, private guns are intended for shooting athletes, manufacturers and sellers of firearms, and for those who need them for construction or as props in film or TV production. Licensed hunters may apply for gun ownership, but they must go through a rigorous qualification process and are only allowed to keep their guns at home during hunting season. Other times of the year, the firearms must be stored at the local police department. Otherwise, only authorized personnel in security-related fields can be in possession of firearms, and often, police officers choose not to carry them. Trigger envisions a world where gun control laws in Korea are ignored Trigger, a Netflix K-drama from writer-director Kwon Oh-seung (Midnight), imagines what would happen if all of these regulations were ignored, and unregistered, highly deadly firearms started streaming mysteriously and rapidly into the country. Across 10 anxiety-inducing episodes, we follow police protagonist Lee Do (Island's Kim Nam-gil) as he tries to keep Korean society from falling into a panic-induced frenzy, and succumbing to a status quo where gun violence is the norm. The thriller is simultaneously a parable for Korean viewers and a mirror for American viewers, who already live in a society where buying a gun can take as few as five clicks. Who is behind the gun plot in Trigger? The guns in Trigger are being funneled into the country by the fictional International Rifle Union (IRU), a black market arms dealer with immense political and economic power globally. The person behind the plan is Moon Baek (Evilive's Kim Young-kwang). Baek stumbles upon the IRU when as a kid, looking for revenge after being trafficked from Korea to the United States for his organs. Jake, one of the organization's higher-ups, sees something valuable in the desperate, vengeful kid. He raises Baek to be a part of the organization. The IRU's entrance into Korea is facilitated by Baek, who has been diagnosed with six months to live due to cancer. While Baek presumably presents the plan to Jake as a business opportunity, he is really looking for retribution against the country that failed him. Upon his arrival in Korea, Baek murders the man who made his childhood a living hell. He hides bullets in the ceiling of the man's apartment, a signal to officials that everything in Korea is about to change. Baek uses some local gangsters, posing as regular mail couriers, to distribute the guns. He targets individuals who are marginalized for some reason or another. Many of them are physically and mentally bullied by the people in their lives. 'Everyone carries a trigger in their heart,' a psychologist says early in the show's run. Trigger implies that everyone is capable of violence, and it is the job of a functional society not to give its citizens access to a weapon that can so easily lead to violent self-destruction. Lee Do's backstory explained Lee Do serves as a counterpoint to Baek's nihilistic ruthlessness. While Do's childhood may not have been quite as horrific, he didn't have it easy. His parents and brother were killed during a home robbery when he was just a child. Immediately following the incident, Do takes a gun off of Captain Jo's (Kim Won-hae) desk and aims it at the man who killed his family, intending to pull the trigger. The captain talks him out of it, but the moment is a formative one for Do. Jo raises Do as his own, alongside his daughter. Decades later, Lee Do is the Platonic ideal of a policeman, protecting the vulnerable and preferring de-escalation to violence. Until guns start appearing amongst the civilian population, Do chooses not to use a gun himself, still haunted by the lives he took during his years as a soldier. When gun violence starts ramping up, he decides to pick up a gun once again—but only when it is necessary to take someone down. Moon Baek kills Captain Jo While Trigger has a complex cast of characters, Lee Do and Moon Baek are the protagonist and antagonist at its center. Both suffered tragedy as children. One was given the support they needed to become a happy, healthy adult. The other was not, and has grown into a ruthless killer as a result. While Lee Do wants to protect the innocent (and even the guilty) around him, Moon Baek wants to see people suffer like he has. Gun violence is his method. When Lee Do starts getting in Moon Baek's way, the criminal mastermind becomes intrigued by the stalwart cop. To get closer to him, he poses as just another recipient of one of the illegal weapons, and offers his 'help' in trying to stop various shootings. Do almost immediately identifies Baek as one of the people behind the organized influx of guns. However, when the police go to arrest Baek, he uses his immense resources to slip between their fingers and continue to wreak havoc. Captain Jo, Do's surrogate dad, becomes one of Baek's desperate targets when a jeonse fraud drives his daughter to suicide. Jo finds the men who scammed his daughter, confronting them at a karaoke room. When they show no remorse, he starts firing. Lee Do arrives on the scene once Captain Jo has followed one of the men outside. He convinces Jo to put the gun down, asking him not to let the feeling that killing the man will help fool him in this moment. 'How did you bear this pain at such a young age?' Jo asks Do. 'It was all thanks to you, Captain,' Do tells him, embracing his distraught father figure. Baek, who has orchestrated the entire scenario to drive up public anxiety around shootings and to break Do's resolve, doesn't like how the scenario ends. He comes out of the shadows to shoot both Captain Jo and Lee Do. 'Just wait and see,' Baek tells Do as he loses consciousness. 'You'll wake up to a whole new world.' The ending of Trigger explained As intended by Baek, Do is out of the action for at least a few days following the incident. When he wakes back up, he is devastated to learn that Captain Jo has died. He grieves Jo and her daughter, acting as the chief mourner at their funeral. Meanwhile, Baek has announced to the public that anyone who wants a gun in Korea can get one. Public fear is at an all-time high as thousands of weapons are delivered to the populace, and incidents of gun violence become more common as a result. On the news, political pundits begin to debate whether gun ownership should be legalized in Korea. The president is considering martial law. A 'Free Guns' rally is organized by Baek to pit the two sides of the argument against one another. Lee Do leaves the funeral in order to attend. Baek has a truck filled with boxes of weapons driven into the middle of the rally. Chaos breaks out as people frantically grab the weapons, thinking they need them to protect themselves. Baek sets off smoke bombs to further confuse the crowd. As Lee Do makes his way to Baek, he remembers a philosophical argument they had over dinner, before Do realized Baek's villainy. 'Wouldn't pulling a 5-milimeter trigger in pursuit of revenge spread fear in the minds of many?' Do told Baek. 'Out of fear that they might die without a gun, everyone will rush to get one. And a society like that will soon be destroyed.' Baek wants to create that society, and he is well on his way. 'It was this world that made the people angry,' he tells Do, making the bad faith argument. 'All I did was hand them a gun. It's up to them whether they pull the trigger.' In the smoky plaza, as scared people point guns at one another, Baek taunts Do. 'What I want is a single gun shot … that will make these people start shooting at each other' He wants Lee Do to be the one to pull the trigger. Baek disappears into the smoke and Do follows, gun drawn. Before he can find the man, a gun shot rings out. Baek has been shot, perhaps by his own hand. The plaza erupts into gunfire. In the chaos, Do sees a boy alone, crying for his mother, a gun in his hands. It is an echo of the boy he once was. Rather than defend himself, Do drops his gun and rushes to him. He embraces the child as the gunfire continues. 'It's okay. You're safe,' he tells him. The image is captured by a livestreamer on the scene. It stops nurse So-hyeon, whom we have been following throughout the series, from using a gun to kill the co-workers who bully her. Once the dust has settled, and scores of people are dead, the image of Lee Do embracing the scared child becomes a symbol of choosing empathy over violence. Later, we see the image at a memorial for the victims of the shooting. Another message at the memorial states: 'We will remember the innocent lives lost and work to create a safer world.' Does Moon Baek die at the end of Trigger? Baek is in a coma following the events of the firefight. The doctor tells Do, who visits Baek in the hospital, that he is unlikely to recover, due to his cancer and the blood loss sustained from the gunshot wound. Later, we see an English-speaking cabal of IRU members, including Jake, vaguely discussing their next business move. A woman walks into the wards where Baek is unconscious, presumably to kill him. Does Trigger have a happy ending? The ending of Trigger isn't happy, but it is hopeful. Across the country, the police hold illegal firearm drop-off drives to collect as many of the weapons as possible. One of the people who drops off a fun is nurse So-hyeon. "It took too long," she tells Officer Jang, who collects her signature. "You did the right thing,' he tells her. Lee Do survives to de-escalate another day. In an echo of what Captain Jo did for him, Do adopts the child he saved in the firefight. He picks the boy up from school, and holds his hand as he walks him home. Do is doing what he can.
Business Wire
an hour ago
- Business Wire
Sun Nuclear to Highlight New Quality Management Solutions at 2025 AAPM Annual Meeting
MELBOURNE, Fla.--(BUSINESS WIRE)-- Sun Nuclear, a Mirion Medical company, will present significant additions to its comprehensive portfolio of Radiation Therapy Quality Management solutions at the 2025 American Association of Physicists in Medicine (AAPM) Annual Meeting, taking place July 27-29, in Washington, D.C. Attendees are invited to explore new software and hardware innovations designed to help elevate treatment quality, streamline workflows, and support safer care. Premiering at AAPM 2025 AdaptCHECK™ Software: AdaptCHECK is a groundbreaking quality assurance (QA) solution for adaptive therapy, enabling fast, patient-specific QA for Varian Medical Systems ® Ethos™ Therapy. Built on the SunCHECK ® Patient workflow, AdaptCHECK supports secondary dose calculations for pre-treatment QA, plan-of-the-day calculations for real-time adjustments based on patient anatomy, and quick plan re-calculations to keep treatments on track. Plan AI™ Software: Plan AI* is an AI-powered treatment planning assistant from Oncospace, now part of Sun Nuclear. The application saves time and drives continuous improvement in plan quality by providing predictive, patient-specific insights on achievable goals before planning begins. It further saves time by streamlining communication and accelerating decision-making. SunSILICON™ Detectors: Expanding the Sun Nuclear detector portfolio, SunSILICON detectors mark an intelligent evolution from the widely adopted EDGE Detector™. These precision-engineered silicon diodes are optimized for advanced relative photon and electron dosimetry, designed for SRS and SBRT, and are compatible with the cylindrical SunSCAN™ 3D water phantom. The SunSILICON model is ideal for very small photon fields and electron dosimetry. The shielded SunSILICON P model is optimized for small to large photon fields. evrCAM™ Cameras: A radiation-tolerant pan-tilt-zoom camera, evrCAM offers superior lifetime and low-light visibility, supporting reliable monitoring in radiation environments, efficient clinical workflows and enhanced patient safety. evrCAM is designed for seamless integration into treatment rooms regardless of linac type – providing clinicians with clear video for enhanced patient observation by eliminating pixelated and damaged images. Additional featured solutions include: the latest version of the SunCHECK Platform for centralized, standardized Quality Management; SciMoCa™ for Monte Carlo-based independent verification of online adaptive secondary dose calculations from Elekta ® Unity™ systems; and Gateway™, a patient data conversion solution for Pinnacle™ treatment planning. In-Booth Education and Demonstrations Throughout AAPM 2025, Sun Nuclear will host a series of presentations and hands-on demonstrations in booth 5000. Topics will span AI-powered planning, adaptive QA workflows, detector technology, and clinical use cases—delivered by both internal experts and leading clinical physicists from across the field. 'We are excited to join the medical physics community at AAPM this year, and to present a range of meaningful advancements that reflect our commitment to smarter, safer radiation therapy," said Luis Rivera, President of Sun Nuclear and Executive Vice President of Mirion Medical. "From AI-powered planning tools and adaptive-focused QA to precision detectors and robust monitoring solutions, our expanded portfolio is aimed at helping clinicians drive efficiency, elevate care, and prepare for the future of patient-centric treatment.' To learn more, visit * Plan AI software for prostate and head and neck, thoracic, abdomen, and pelvis radiotherapy is FDA 510(k) cleared, and for sale in the United States only. About Sun Nuclear Sun Nuclear is part of Mirion Medical, a group of healthcare-focused brands within Mirion, providing innovative solutions for Radiation Therapy and Diagnostic Imaging. More than 6,000 cancer centers worldwide rely on us for independent, integrated Quality Management. With a focus on ongoing support, Sun Nuclear aims to ease technology adoption, enhance workflows and improve outcomes – so that healthcare providers can achieve real results for Patient Safety. Learn more: Sun Nuclear, AdaptCHECK, SunCHECK, Plan AI, SunSILICON, SunSCAN 3D and evrCAM are trademarks or registered trademarks of Mirion Technologies, Inc. and/or its affiliates in the United States and/or other countries. Varian Medical Systems® is a registered trademark, and Ethos™ is a trademark, of Varian Medical Systems, Inc. Sun Nuclear Corporation is not affiliated with or sponsored by Varian Medical Systems, Inc.
